Highlights Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Real-time Estimate Cboe BZX Other stock markets 03:59:36 2024-04-29 pm EDT			5-day change	1st Jan Change
8.995 ^USD	-1.59%		+0.78%	+21.74%

Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ
Mar. 28	Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Talis Biomedical Corporation Announces New Data Supporting the Development of Its Planned CT/NG/TV and Vinal Infections Panels	23-07-27	CI
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-22	AQ
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Reports Q4 Revenue $0.3M	23-03-22	MT
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-03	AQ
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Posts Q3 Revenue $796,000	22-11-03	MT
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-02	AQ
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
Earnings Flash (TLIS) TALIS BIOMEDICAL CORPORATION Posts Q2 Revenue $0.6M	22-08-02	MT
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-10	AQ
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-03-15	AQ
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15	CI
Talis Biomedical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-15	CI
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-11-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Highlights

Filters